Sponsor

Great Lakes NeuroTechnologies Inc.

Clinical research sponsor

Published trials16
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

16 shown
DiSCERN: Advanced PD Therapy Candidacy and Evaluation SystemNCT05351580 · lead sponsor · 2022-07-21
COMPLETED
Objective Quality of Life Detection ValidationNCT04121793 · lead sponsor · 2019-09-20
COMPLETED
Patient-Centered PD Ambulatory Monitoring SystemNCT04142528 · lead sponsor · 2019-07-01
UNKNOWN
Automated Deep Brain Stimulation Programming Using Functional MappingNCT02765282 · lead sponsor · 2018-10-01
UNKNOWN
Kinesia 360 Parkinson's Monitoring StudyNCT02657655 · lead sponsor · 2016-01-01
COMPLETED
BradyXplore Phase II: Bradykinesia Feature Extraction SystemNCT02358876 · lead sponsor · 2015-02-01
COMPLETED
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy TitrationNCT02125825 · lead sponsor · 2014-07-01
COMPLETED
Automated Telehealth Diagnostics for Remote Parkinson MonitoringNCT02152319 · lead sponsor · 2014-05-01
COMPLETED
ParkinStim: Transcranial Direct Current Stimulation for Parkinson's DiseaseNCT02125383 · lead sponsor · 2014-04-01
COMPLETED
Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBSNCT02080572 · lead sponsor · 2014-02-01
COMPLETED
Pilot Study for Automated Deep Brain Stimulation ProgrammingNCT02046863 · lead sponsor · 2013-11-01
COMPLETED
Kinesia HomeView - Home Diary ComparisonNCT01920425 · lead sponsor · 2013-07-01
COMPLETED
Movement Disorder Quantification Algorithm DevelopmentNCT01534650 · lead sponsor · 2012-02-01
COMPLETED
Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) ProgrammingNCT01429220 · lead sponsor · 2011-08-01
COMPLETED
Capturing Parkinson's Disease Medication Side Effects During Daily ActivitiesNCT01429207 · lead sponsor · 2011-08-01
COMPLETED
Tele-diagnostics for Remote Parkinson's MonitoringNCT01356056 · lead sponsor · 2011-05-01
COMPLETED

Sponsor roles

lead sponsor16

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.